GlassScriptPhysician profile
Sarah Dawn Allende
NPI 1528623931
$1,638.83
in general payments reported to CMS, 2019-2025
19 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $293 · 2023: $329 · 2024: $669 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,345.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $438.40 | 2022-2024 | |
| Novo Nordisk INC | $259.85 | 2023-2025 | Wegovy |
| Shield Therapeutics INC | $228.85 | 2024-2025 | |
| Lilly USA, LLC | $138.71 | 2022-2025 | Zepbound, Mounjaro, Emgality |
| Ibsa Pharma INC. | $127.13 | 2023-2025 | Tirosint, Tirosint, Licart |
| Organon LLC | $55.43 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $39.56 | 2025 | |
| Pfizer INC. | $37.82 | 2023 | |
| Dexcom, INC. | $36.96 | 2025 | Dexcom G6 Transmitter |
| Acella Pharmaceuticals, LLC | $35.58 | 2023-2025 | NP Thyroid 60 |
| Hologic Sales and Service, LLC | $35.30 | 2022 | |
| Sage Therapeutics, LLC | $34.59 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $34.58 | 2024 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $32.04 | 2022 | |
| Lundbeck LLC | $25.19 | 2025 | Vyepti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.74 | 2024 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $20.65 | 2022 | |
| Antares Pharma, INC. | $18.87 | 2024 | Xyosted |
| Abbott Laboratories | $15.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Allende listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.